ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Therapeutic Response of Late Clinical Cell Mediated Rejection is Modeled by Chronicity Changes

I. Melgarejo1, V. Visnawathan2, A. Sharma1, P. Sood1, C. Puttarajappa1, C. Wu1, N. Shah1, M. Molinari1, S. Hariharan1, R. Mehta1

1Starzl Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, 2Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh Medical Center, Pittsburgh, PA

Meeting: 2021 American Transplant Congress

Abstract number: 240

Keywords: Glucocortocoids, Graft function, Rejection

Topic: Clinical Science » Kidney » Kidney: Acute Cellular Rejection

Session Information

Session Name: Kidney: Acute Cellular Rejection

Session Type: Rapid Fire Oral Abstract

Date: Monday, June 7, 2021

Session Time: 4:30pm-5:30pm

 Presentation Time: 5:05pm-5:10pm

Location: Virtual

*Purpose: Although there is a tendency to treat late clinical TCMR, the responsiveness to steroids is unclear.

*Methods: Among kidney transplant recipients, transplanted between Jan 2013 and December 2017, we followed clinical rejections (beyond 6months) in a cohort of patients who had undergone a 3 month surveillance biopsy and no episodes of clinical rejection. Of the 62 patients who had a late rejection, 45 had pure TCMR (Banff IA/IB in severity). The majority of the patients (>95%) were induced with thymoglobulin at the time of transplant. Those who were diagnosed to have TCMR were treated with steroids 250 mg iv for a total of 3 doses. We compared baseline GFR, GFR at time of biopsy and the best GFR within 3 months of rejection treatment in the TCMR group. Based on the GFR response, the patients were divided into those that continued to have worsening GFR post treatment (n=12) and those where GFR stabilized or improved post treatment (n=33). Based on the binary variable of response to treatment, a multivariable logistic regression was performed taking into consideration recipient age, sex, race, sensitization, DGF and DSA. We used the total i score to account for inflammation in the scarred areas.

*Results: The median change in GFR among all clinical TCMR was 4 ml/min (IQR -0.5 to 7.8). Multivariable analysis revealed IFTA score>2 (p=0.017; OR 7.6, CI 1.4-40) was associated with lack of improvement post treatment.

*Conclusions: 1. Therapeutic response of pure late T cell mediated rejection to steroids is modest at best, with a median change in GFR of only 4 ml/min. 2. IFTA score of greater than 2 was associated with a poor therapeutic response in pure TCMR. 3. Factors impacting response to late TCMR should be analyzed in larger studies given poor responsiveness to treatment.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Melgarejo I, Visnawathan V, Sharma A, Sood P, Puttarajappa C, Wu C, Shah N, Molinari M, Hariharan S, Mehta R. Therapeutic Response of Late Clinical Cell Mediated Rejection is Modeled by Chronicity Changes [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/therapeutic-response-of-late-clinical-cell-mediated-rejection-is-modeled-by-chronicity-changes/. Accessed March 26, 2023.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2023 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences